Fort Lee, New Jersey - August 4, 2026 - Nuvectis Pharma, Inc. (NVCT), a biopharmaceutical company concentrating on novel therapies for complement-related ailments and oncology, disclosed its financial outcomes for Q2 2026. The company also shared recent business advancements.